These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
604 related items for PubMed ID: 19596414
1. Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus. Sasaki T, Kokumai N, Ohgitani T, Sakamoto R, Takikawa N, Lin Z, Okamatsu M, Sakoda Y, Kida H. Vaccine; 2009 Aug 20; 27(38):5174-7. PubMed ID: 19596414 [Abstract] [Full Text] [Related]
2. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia. Isoda N, Sakoda Y, Kishida N, Soda K, Sakabe S, Sakamoto R, Imamura T, Sakaguchi M, Sasaki T, Kokumai N, Ohgitani T, Saijo K, Sawata A, Hagiwara J, Lin Z, Kida H. Arch Virol; 2008 Aug 20; 153(9):1685-92. PubMed ID: 18651092 [Abstract] [Full Text] [Related]
5. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens. Jadhao SJ, Lee CW, Sylte M, Suarez DL. Vaccine; 2009 Oct 19; 27(44):6247-60. PubMed ID: 19686695 [Abstract] [Full Text] [Related]
7. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype. Pavlova SP, Veits J, Mettenleiter TC, Fuchs W. Vaccine; 2009 Aug 13; 27(37):5085-90. PubMed ID: 19573638 [Abstract] [Full Text] [Related]
8. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions. Veits J, Römer-Oberdörfer A, Helferich D, Durban M, Suezer Y, Sutter G, Mettenleiter TC. Vaccine; 2008 Mar 20; 26(13):1688-96. PubMed ID: 18291561 [Abstract] [Full Text] [Related]
12. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI. Vaccine; 2006 Nov 17; 24(47-48):6859-66. PubMed ID: 17050041 [Abstract] [Full Text] [Related]
14. Intraocular vaccination with an inactivated highly pathogenic avian influenza virus induces protective antibody responses in chickens. Hikono H, Mase M, Matsuu A, Nakayama M, Saito T. Vet Immunol Immunopathol; 2013 Jan 15; 151(1-2):83-9. PubMed ID: 23159237 [Abstract] [Full Text] [Related]
16. An inactivated H5N2 vaccine reduces transmission of highly pathogenic H5N1 avian influenza virus among native chickens. Poetri ON, Bouma A, Murtini S, Claassen I, Koch G, Soejoedono RD, Stegeman JA, van Boven M. Vaccine; 2009 May 11; 27(21):2864-9. PubMed ID: 19428896 [Abstract] [Full Text] [Related]
18. Longitudinal 2 years field study of conventional vaccination against highly pathogenic avian influenza H5N1 in layer hens. Rudolf M, Pöppel M, Fröhlich A, Breithaupt A, Teifke J, Blohm U, Mettenleiter T, Beer M, Harder T. Vaccine; 2010 Oct 04; 28(42):6832-40. PubMed ID: 20727963 [Abstract] [Full Text] [Related]